New bacterial mRNA vaccine technology shows promise in fighting plague, and could help address the global threat of ...

Lumos Diagnostics shares today soared by more than 150pc after the company unveiled a US distribution deal worth as much as ...

FebriDx® is a first-in-class rapid test that differentiates between bacterial and non-bacterial respiratory infections, offering significant potential to address critical unmet needs in patient care ...

First patient dosing in Company’s Phase 2b trial marks pivotal milestone in phage therapy development program targeting ...

BiomX has dosed the first subject in the randomised Phase IIb trial of the company’s fixed multi-phage therapy, BX004, to ...

A recent review by researchers at Philadelphia College of Osteopathic Medicine (PCOM) shows Chlamydia pneumoniae (Cpn) and ...

Repeatedly planting the same crop can make soil sick, as decaying plant DNA builds up and harms new plants. Scientists found ...

Although rare, an untreated bacterial sinus infection can cause severe complications. Learn more here.

Scientists at Tel Aviv University and the Israel Institute for Biological Research have developed the first mRNA vaccine proven completely effective against deadly bacteria. This groundbreaking ...

Removing incorrect penicillin allergy labels could improve care, reduce NHS costs and help tackle bacterial resistance, ...

EPHA4 pathway dysfunction causes axon pathfinding defects, resulting in impaired coordinated left-right locomotion by disrupting neural patterning and the function of central pattern generators, ...

Researchers at MIT and other institutions have identified compounds that can fight off viral infection by activating a ...